NCT00771043View on ClinicalTrials.gov

A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 1, 2008

Primary Completion Date

August 1, 2009

Study Completion Date

June 1, 2010

Conditions
Relapsing-remitting Multiple Sclerosis
Interventions
DRUG

TYSABRI and AVONEX

TYSABRI and AVONEX treatment per package insert.

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT00771043 - A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a | Biotech Hunter | Biotech Hunter